Hund I, Hess ME, Andrieux G, Stomper J, et al. Genetic and epigenetic alterations at secondary resistance after continued decitabine-based treatment of acute myeloid leukemia in the randomized phase II DECIDER trial. Leukemia 2025 Oct 7. doi: 10.1038/s41375-025-02780.
PMID: 41057684